Visual Quality Following Aspheric Intraocular Lens (IOL) Implantation - a Comparative Clinical Study
Not Applicable
Completed
- Conditions
- AphakiaCataract
- Registration Number
- NCT01544777
- Lead Sponsor
- Hoya Surgical Optics, Inc.
- Brief Summary
To evaluate visual acuity and quality of vision in participants undergoing cataract surgery with a Hoya model 751 intra-ocular lens and to compare the visual results to the common monofocal lens in use.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
- Senile cataract
- Patient identified as a candidate for cataract surgery and IOL implantation
- Willing to sign informed consent document approved by the Ethical Committee
- Willing to complete all required tests and exams per this protocol
Exclusion Criteria
- Amblyopia
- History or evidence of any ocular disease that may affect visual acuity
- Previous ocular surgery, including refraction surgery
- Ocular anomalies (e.g. microphthalmos, kerataconous)
- Subjects with greater than 1.0 D of corneal astigmatism
- Subjects who experience intraoperative complications that could affect postoperative IOL centration or tilt
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Primary Outcome Measures
Name Time Method Uncorrected Visual Acuity (UCVA) (ETDRS)for distance, intermediate and near Up to 3 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which aspheric IOLs improve visual quality in cataract patients compared to monofocal lenses?
How does the Hoya iSert 751 lens compare to standard monofocal IOLs in correcting higher-order aberrations post-cataract surgery?
What biomarkers or patient characteristics predict optimal outcomes with aspheric IOL implantation in NCT01544777?
What are the potential adverse events associated with Hoya model 751 IOLs and how do they compare to traditional IOLs?
How do aspheric IOLs like Hoya iSert 751 influence retinal image quality metrics compared to monovision approaches?
Trial Locations
- Locations (1)
Sir Charles Gairdner Hospital
🇦🇺Nedlands, Western Australia, Australia
Sir Charles Gairdner Hospital🇦🇺Nedlands, Western Australia, Australia